Dry-powder inhaler

Alpaca Launches Private Equity Real Estate Platform

Retrieved on: 
Friday, September 29, 2023
Building Systems, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Data Management, Technology, Finance, Blockchain, Professional Services, Asset Management, Transport, REIT, Software, Logistics, Supply Chain Management, Internet, Other Construction & Property, Partnership, GCM Grosvenor, AllianceBernstein, Prospect Ridge Academy, General partnership, Ares Management, Dislocation, Investment, J. P. Morgan, ARE, Property technology, Real estate, Dry-powder inhaler, Commercial property, Alpaca

Alternative investments management firm Alpaca (or the “Firm”) announced today the launch of Alpaca Real Estate (or “ARE”).

Key Points: 
  • Alternative investments management firm Alpaca (or the “Firm”) announced today the launch of Alpaca Real Estate (or “ARE”).
  • In addition, we expect Alpaca’s expertise will allow us to implement technology more efficiently than the typical real estate owner, and in doing so create upside opportunities.”
    Weiss added, “Establishing Alpaca Real Estate allows us to combine what we believe are strong baseline real estate returns with the potential upside associated with operational and technology-driven overlays.
  • Alpaca Real Estate was created to drive technology utilization from the bottom up by bridging the gap between real estate users and PropTech firms.
  • “We believe that Alpaca is advantageously positioned to capitalize on the growing trend of investing at the intersection of real estate and technology.”

Global Digital Dose Inhaler Market Primed for Remarkable Growth, Forecasted to Reach $53.32 Billion by 2030

Retrieved on: 
Friday, August 25, 2023
Inhaler, COPD, Asthma, MDI, Prevalence, DPI, Chronic lung disease, MEA, Economic development, U.S. FDA, Compound annual growth rate, Ageing, Chlorofluorocarbon, Digital health, FDC, Growth, Dry-powder inhaler, FDA, Pharmaceutical industry, Poultry farming

The global digital dose inhaler market is projected to experience substantial growth, with a projected market size of $53.32 billion by 2030, exhibiting an impressive Compound Annual Growth Rate (CAGR) of 19.4% from 2023 to 2030.

Key Points: 
  • The global digital dose inhaler market is projected to experience substantial growth, with a projected market size of $53.32 billion by 2030, exhibiting an impressive Compound Annual Growth Rate (CAGR) of 19.4% from 2023 to 2030.
  • This growth is driven by several key factors, including the increasing elderly population and the rising prevalence of chronic respiratory diseases.
  • These expansion strategies are expected to drive the adoption of digital dose inhalers and contribute to long-term growth and profitability.
  • This in turn has driven the demand for innovative respiratory devices, further stimulating growth in the digital dose inhaler market during the forecast period.

Global Digital Dose Inhalers Market Report to 2027: North America is Expected to Dominate the Market - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 21, 2023
Pharmaceutical, Health, Medical Devices, Inhaler, COPD, NORTH, Smoker, Asthma, MDI, Prevalence, DPI, Administration, Greenhouse gas, Dry-powder inhaler, Organization, Economy, Chlorofluorocarbon, Medicine, AMERICA, Chronic obstructive pulmonary disease, Death, Isocyanate, Digital technology, Azerbaijan and Organization for Economic Co-operation, Roflumilast, Metered-dose inhaler, Dust, Cystic fibrosis, Global Burden of Disease Study, Growth, WHO, Air pollution, CO2, DIGITAL, World Health Organization, Pharmaceutical industry, Geography

Therefore, the market for digital dose inhalers is estimated to grow at a substantial CAGR during the forecast period from 2022 to 2027.

Key Points: 
  • Therefore, the market for digital dose inhalers is estimated to grow at a substantial CAGR during the forecast period from 2022 to 2027.
  • One of the key aspect for driving the digital dose inhalers market is the rising prevalence of various respiratory disorders globally.
  • DIGITAL DOSE INHALERS MARKET SEGMENT ANALYSIS:
    Digital Dose Inhalers Market by Product Type (Dry Powder Inhalers and Metered Dose Inhalers), Application (Chronic Obstructive Pulmonary Disease, Asthma, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
  • NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL DIGITAL DOSE INHALERS MARKET:
    Among all the regions, North America is expected to dominate the global digital dose inhalers market in the year 2021 and is expected to do the same during the forecast period from 2022-2027.

Respiratory Inhalers Market Report 2023-2033

Retrieved on: 
Tuesday, January 3, 2023
Organization, Drug class, Table, Mouth, NCBI, Dry-powder inhaler, ICS, Mode, Government, Chronic obstructive pulmonary disease, Asthma, Growth, Recession, COVID-19, CDC, Region, Medicare, SAMA, LAMA, Degenerative disease, Perception, Immunity, COPD, Prevalence, Throat, Market, SABA, LABA, Pulmonary hypertension, Spirometry, Data analysis, Pharmaceutical industry, Liquor, Fossil fuel, Marketing, Oil, Fluticasone/salmeterol

NEW YORK, Jan. 3, 2023 /PRNewswire/ -- Forecasts by Product Type (Standard Pressurised Metered-Dose Inhalers, Pressurised Metered-dose Inhalers, Metered-Dose Inhaler with a Spacer, Dry Powder Inhalers, Soft Mist Inhalers, Others), by Drug Class (ICS, SABA+ICS, SABA, LABA, LAMA, ULABA, SABA+SAMA, LABA+LAMA+ICS, SAMA, Others), by Mode of Operation (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices, Others), by Indication (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

Key Points: 
  • • Where is the respiratory inhalers market heading and how can you ensure you are at the forefront of the market?
  • You need to discover how this will impact the respiratory inhalers market today, and over the next 10 years:
    • Our 354-page report provides 126 tables and 184 charts/graphs exclusively to you.
  • This report tells you TODAY how the respiratory inhalers market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce.
  • • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising respiratory inhalers prices and recent developments.

Raiven Capital Invests in Data Protection Firm Trilio

Retrieved on: 
Wednesday, December 14, 2022
Finance, Data Management, Professional Services, Technology, Software, Capital, Environment, DLT, OpenStack, Dry-powder inhaler, Raiven, Growth, Safety, Engineering, Health, Silicon, DevOps, IOT, Cryptocurrency, Risk management

Raiven Capital, a global early-stage tech venture fund, announced its investment in Trilio, a cloud-based data protection and management software.

Key Points: 
  • Raiven Capital, a global early-stage tech venture fund, announced its investment in Trilio, a cloud-based data protection and management software.
  • And we are excited to invest in Trilio, which anticipates the next technology of data storage and security.
  • Trilio is a leader in cloud-native cybersecurity and data protection.
  • Raiven Capital is a global early-stage technology venture fund with roots in Silicon Valley and Toronto focusing on AI, DLT and IoT.

Smart Inhalers Market Size, Share & Trends Analysis Report By Type, By Indication, By Distribution Channel, By End-use, By Region And Segment Forecasts, 2022 - 2030

Retrieved on: 
Thursday, December 15, 2022
Asthma, Chronic Respiratory Disease, Medicine, Cavity ring-down spectroscopy, MDIS, Patient, Prevalence, Hospital, Degenerative disease, Inhaler, Chronic obstructive pulmonary disease, Dry-powder inhaler, Market share, Incidence, DPI, Pharmacy, Metered-dose inhaler, COVID-19, Health, Growth, COPD, USD, Cystic fibrosis, Pharmaceutical industry, Healthcare

View original content:https://www.prnewswire.com/news-releases/smart-inhalers-market-size-shar...

Key Points: 
  • Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2022 - 2030
    The global smart inhalers market size is expected to reach USD 53.3 billion by 2030., expanding at a CAGR of 19.3% from 2022 to 2030.
  • According to the European Respiratory Society Congress, COPD is expected to affect over 480 million people in 2022 across the globe.
  • COVID-19 has increased the demand for smart inhalers due to the rising penetration of cutting-edge digital devices and solutions for respiratory and pulmonary care.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Raiven Exits Fintech Platform Whizmo

Retrieved on: 
Thursday, October 13, 2022
Software, Professional Services, Business, Fintech, Data Management, Start-Up, IOT (Internet of Things), Payments, Technology, Artificial Intelligence, Other Professional Services, Finance, Method, LinkedIn, Raiven, Female, IOT, Growth, DLT, General partnership, B2C, Twitter, Artificial intelligence, Capital, Science and technology in Asia, Health, IP, Environment, Silicon, Dry-powder inhaler, Bank, Cryptocurrency, Facebook, Software, Professional Services, Business, Fintech, Data Management, Start-Up, IOT (Internet of Things), Payments, Technology, Artificial Intelligence, Other Professional Services, Finance

Raiven Capital, a global early-stage tech venture fund, today announced its exit from fintech company Whizmo, a mobile money start-up that provides B2B and B2C financial services for customers and merchants in emerging economies.

Key Points: 
  • Raiven Capital, a global early-stage tech venture fund, today announced its exit from fintech company Whizmo, a mobile money start-up that provides B2B and B2C financial services for customers and merchants in emerging economies.
  • Raiven Capital invested in Whizmo in 2020 and exited the company this summer at a significant multiple to a private equity investor, said Paul Dugsin, General Partner, Raiven Capital.
  • Whizmo worked with Raiven in the seed stage to form a Canadian holding company, where its IP is held.
  • Once growth is robust, Raiven exits to later-stage capital in Silicon Valley and beyond.

Raiven Capital Invests in Wayout

Retrieved on: 
Tuesday, September 27, 2022
Technology, Other Professional Services, Business, Finance, Environmental Issues, Environmental Health, Professional Services, Other Natural Resources, Environment, IOT (Internet of Things), Sustainability, Software, Natural Resources, Data Management, Seawater, Health, Capital, Groundwater, Drinking water, Efficiency, Twitter, LinkedIn, Growth, Dry-powder inhaler, Environment, Thought, CEO, Internet, DLT, Founder, Drinking, Water, Silicon, Raiven, Artificial intelligence, Renewable energy, Facebook

Raiven Capital, a global early-stage tech venture fund, today announced its investment in Wayout, an IoT-enabled, water purification system that can turn all kinds of source water, even seawater, into drinkable water.

Key Points: 
  • Raiven Capital, a global early-stage tech venture fund, today announced its investment in Wayout, an IoT-enabled, water purification system that can turn all kinds of source water, even seawater, into drinkable water.
  • We are thrilled to invest in Wayout, especially as clean water should be a basic human right, said Paul Dugsin, Raiven Capital General Partner.
  • Raiven Capital is a global early-stage technology venture fund with roots in Silicon Valley and Toronto focusing on opportunities in Artificial Intelligence, DLT and Internet of Things.
  • Once growth is robust, Raiven exits its portfolio companies to later-stage capital in Silicon Valley and beyond.

Dynasty Financial Partners Closes a $50 Million Credit Facility from RBC Capital Markets and a Consortium of Lenders to Power Growth and Strategic Initiatives

Retrieved on: 
Tuesday, September 27, 2022
Finance, Banking, Professional Services, Technology, Software, Software, Movement, Human, RBC, UMB, UMB Financial Corporation, RIAS, Growth, Goldman Sachs, RBC Capital Markets, Social media, Focus Financial Partners, Dynasty, Royal Bank of Canada, Solution, Citibank, Dry-powder inhaler, J. P. Morgan, Citigroup, Security (finance), Financial services

and J.P. Morgan joining RBC as Joint Lead Arrangers and Joint Book Runners.

Key Points: 
  • and J.P. Morgan joining RBC as Joint Lead Arrangers and Joint Book Runners.
  • as well as Goldman Sachs Bank USA will also a member of the syndicate.
  • Dynasty will use the new credit facility to maintain and grow its cutting-edge technology, intellectual capital, integrations, and capabilities to support its network partners, in addition to other strategic investments through its Capital Strategies offering.
  • Dynasty is a provider of technology-enabled wealth management solutions and business services for financial advisory firms primarily focused on serving high net worth and ultra-high net worth clients.

Global Digital Dose Inhalers Market Trajectory & Analytics Report 2022: High Prevalence of Respiratory Diseases Keeps Digital Dose Inhalers Market in Hale & Hearty Condition - ResearchAndMarkets.com

Retrieved on: 
Monday, August 22, 2022
Health, General Health, Patient, COVID-19, Digital, Death, Awareness, Ageing, Administration, Obstructive sleep apnea, Degenerative disease, Chronic obstructive pulmonary disease, Asthma, Interferon beta-1a, Inhalation, Quality of life, Metered-dose inhaler, Dry-powder inhaler, Prevalence, CAGR, COPD, Population, Compliance, Measuring instrument, Growth, Chlorofluorocarbon, Pharmaceutical industry, Pet, Vaccine

The "Digital Dose Inhalers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digital Dose Inhalers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Digital dose inhalers deliver accurate amount of drug to patient's lungs as a short burst of aerosolized medication.
  • Growth in the global market is poised to benefit from rising prevalence of various respiratory disorders, favorable reimbursement policies and technological advances.
  • Metered dose inhalers are gaining from rising cases of respiratory conditions including chronic respiratory disorders, chronic obstructive pulmonary diseases and asthma.